Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi‐centre double‐blind study

S. Sontag,M. Robinson,W. Roufail,B. Hirschowitz,S. Sabesin,W. C. Wu,J. Behar,W. Peterson,K. Kranz,A. Tarnawski,Y. Dayal,R. Berman,T. Simon
DOI: https://doi.org/10.1046/j.1365-2036.1997.141317000.x
1997-04-01
Abstract:Introduction: Relapse of erosive oesophagitis occurs in almost all patients if treatment is stopped after initial healing.
What problem does this paper attempt to address?